Levosulpiride
- Generic Name
- Levosulpiride
- Drug Type
- Small Molecule
- Chemical Formula
- C15H23N3O4S
- CAS Number
- 23672-07-3
- Unique Ingredient Identifier
- JTG7R315LK
- Indication
⑴用于治疗内源性和反应性抑郁症，伴有躯体化症状的焦虑症、急慢性精神分裂症的阴性或阳性症状。⑵治疗消化不良，肠道易激惹，反流性食管炎及化疗所致的呕吐。
- Associated Conditions
- Dizziness, Dyspepsia, Nausea, Nausea and vomiting, Tinnitus, Hearing loss or impairment
Helicobacter Pylori Eradication in Functional Dyspepsia
Not Applicable
Completed
- Conditions
- DyspepsiaHelicobacter Pylori Infection
- Interventions
- First Posted Date
- 2021-01-06
- Last Posted Date
- 2021-01-14
- Lead Sponsor
- Sir Ganga Ram Hospital
- Target Recruit Count
- 202
- Registration Number
- NCT04697641
- Locations
- 🇮🇳
Department of Gastroenterology & Hepatology, Sir Ganga Ram Hospital, New Delhi, India
Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema
Phase 2
Recruiting
- Conditions
- Diabetic Macular EdemaDiabetic Retinopathy
- Interventions
- First Posted Date
- 2017-05-22
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Carmen Clapp
- Target Recruit Count
- 120
- Registration Number
- NCT03161652
- Locations
- 🇲🇽
Instituto de la Retina del Bajio SC (INDEREB), Querétaro City, Queretaro, Mexico
🇲🇽Instituto Mexicano de Oftalmologia (IMO), Queretaro, Mexico
Pharmacokinetic Study of Levosulpiride
- First Posted Date
- 2015-06-25
- Last Posted Date
- 2015-06-25
- Lead Sponsor
- Wuhan Union Hospital, China
- Target Recruit Count
- 42
- Registration Number
- NCT02481583
A Study To Evaluate The Efficacy And Safety Of Intramuscular Levosulpiride In Patients With Agitation Of Schizophrenia
Phase 2
Completed
- Conditions
- Agitation
- Interventions
- First Posted Date
- 2009-03-20
- Last Posted Date
- 2010-12-03
- Lead Sponsor
- Shanghai Mental Health Center
- Target Recruit Count
- 240
- Registration Number
- NCT00866645
- Locations
- 🇨🇳
Hebei Mental Health Center, Baoding, Hebei, China
🇨🇳Nanjing Brain Hospital, Nanjing, Jiangsu, China
🇨🇳Xi'an Mental Health Center, Xi'an, Shaanxi, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath